TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 131-142

  Zipris, Danny ^a   Lien, Egil ^a   Xie, Jenny X ^a   Greiner, Dale L ^a   Mordes, John P ^a   Rossini, Aldo A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN P40; PROTEIN P70; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BACTERIOPHAGE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; ESCHERICHIA COLI; FEMALE; HEPATITIS B VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPH NODE; LYMPHOID ORGAN; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RAT STRAIN; STAPHYLOCOCCUS AUREUS; VACCINIA VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 10844295809     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.131     Document Type: Article

References (94)

1. Park, Y., and G.S. Eisenbarth. 2000. The natural history of autoimmunity in type 1A diabetes mellitus. In Diabetes Mellitus: A Fundamental and Clinical Text. D. LeRoith, S. I. Taylor, and J. M. Olefsky, eds. Lippincott Williams & Wilkins, Philadelphia, p. 347.
2. Yoon, J. W., and H.-S. Jun. 2000. Role of viruses in the pathogenesis of type 1 diabetes mellitus. In Diabetes Mellitus: A Fundamental and Clinical Text. D. LeRoith, S. I. Taylor, and J. M. Olefsky, eds. Lippincott Williams & Wilkins, Philadelphia, p. 419.
3. Jun, H. S., and J. W. Yoon. 2003. A new look at viruses in type 1 diabetes. Diabetes Metab. Res. Rev. 19:8.
4. Redondo, M. J., L. Yu, M. Hawa, T. Mackenzie, D. A. Pyke, G. S. Eisenbarth, and R. D. G. Leslie. 2001. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44:354.
5. Mordes, J. P., R. Bortell, H. Groen, D. L. Guberski, A. A. Rossini, and D. L. Greiner. 2001. Autoimmune diabetes mellitus in the BB rat. In Animal Models of Diabetes: A Primer, Vol. 2. A. A. F. Siraa and E. Shafrir, eds. Harwood Academic Publishers, Amsterdam, p. 1.
6. Guberski, D. L., V. A. Thomas, W. R. Shek, A. A. Like, E. S. Handler, A. A. Rossini, J. E. Wallace, and R. M. Welsh. 1991. Induction of type 1 diabetes by Kilham's rat virus in diabetes resistant BB/Wor rats. Science 254:1010.
7. Thomas, V. A., B. A. Woda, E. S. Handler, D. L. Greiner, J. P. Mordes, and A. A. Rossini. 1991. Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes 40:255.
8. Jacoby, R. O., L. J. Ball-Goodrich, D. G. Besselsen, M. D. McKisic, L. K. Riley, and A. L. Smith. 1996. Rodent parvovirus infections. Lab. Anim. Sci. 46:370.
9. Brown, D. W., R. M. Welsh, and A. A. Like. 1993. Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats. J. Virol. 67:5873.
10. Chung, Y. H., H. S. Jun, M. Son, M. Bao, H. Y. Bae, Y. Kang, and J. W. Yoon. 2000. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J. Immunol 165:2866.
11. + T cell populations. J. Immunol. 170:3592.
12. Jun, H. S., and J. W. Yoon. 2001. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 44:271.
13. Stephens, L. A., and D. Mason. 2001. Characterisation of thymus-derived regulatory T cells that protect against organ-specific autoimmune disease. Microbes Infect. 3:905.
14. Saoudi, A., B. Seddon, D. Fowell, and D. Mason. 1996. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J. Exp. Med. 184:2393.
15. - thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer. Eur. J. Immunol. 26:2702.
16. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:235.
17. Ohashi, P. S., and A. L. DeFranco. 2002. Making and breaking tolerance. Curr. Opin. Immunol. 14:744.
18. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. I:135.
19. Lien, E., and R. R. 2002. Ingalls: Toll-like receptors. Crit. Care Med. 30:S1.
20. Barton, G. M., and R. Medzhitov. 2002. Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 270:81.
21. Medzhitov, R., and C. J. Janeway, Jr. 2000. Advances in immunology: innate immunity. N. Engl. J. Med. 343:338.
22. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173:89.
23. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.
24. Mordes, J. P., D. V. Serreze, D. L. Greiner, and A. A. Rossini. 2004. Animal models of autoimmune diabetes mellitus. In Diabetes Mellitus: A Fundamental and Clinical Text. D. LeRoith, S. I. Taylor, and J. M. Olefsky, eds. Lippincott Williams & Wilkins, Philadelphia, p. 591.
25. Oldstone, M. B. 1988. Prevention of type 1 diabetes in nonobese diabetic mice by virus infection. Science 239:500.
26. Oldstone, M. B. A. 1990. Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J. Exp. Med. 171:2077.
27. Oldstone, M. B. A., R. Ahmed, and M. Salvato. 1990. Viruses as therapeutic agents. II. Viral reassortants map prevention of insulin-dependent diabetes mellitus to the small RNA of lymphocytic choriomeningitis virus. J. Exp. Med. 171:2091.
28. Cooke, A., P. Tonks, F. M. Jones, H. O'Shea, P. Hutchings, A. J. C. Fulford, and D. W. Dunne. 1999. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 21:169.
29. Bras, A., and A. P. Aguas. 1996. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology 89:20.
30. Sai, P., and A. S. Rivereau. 1996. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments: comparative efficiency of human insulin and two bacterial antigens, lipopolysaccharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Diabetes Metab. 22:341.
31. Tian, J., D. Zekzer, L. Hanssen, Y. Lu, A. Olcott, and D. L. Kaufman. 2001. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167:1081.
32. Quintana, F. J., P. Carmi, and I. R. Cohen. 2002. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J. Immunol. 169:6030.
33. Quintana, F. J., A. Rotem, P. Carmi, and I. R. Cohen. 2000. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity. J. Immunol. 165:6148.
34. Serreze, D. V., K. Hamaguchi, and E. H. Leiter. 1989. Immunostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 2:759.
35. Yang, H. Y., P. L. Dundon, S. R. Nahill, and R. M. Welsh. 1989. Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J. Immunol. 142:1710.
36. Ellerman, K. E., C. A. Richards, D. L. Guberski, W. R. Shek, and A. A. Like. 1996. Kilham rat virus triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes 45:557.
37. Schluesener, H. J., K. Seid, M. Deininger, and J. Schwab. 2001. Transient in vivo activation of rat brain macrophages/microglial cells and astrocytes by immuno-stimulatory multiple CpG oligonucleotides. J. Neuroimmunol. 113:89.
38. Hemmi, H., T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, K. Hoshino, T. Horiuchi, H. Tomizawa, K. Takeda, and S. Akira. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196.
39. Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567.
40. Nie, N. H., C. H. Hull, J. G. Jenkins, K. Steinbrenner, and D. H. Bent. Statistical Package for the Social Sciences. McGraw-Hill, New York, p. 1.
41. Glantz, S. A. Primer of Biostatistics. McGraw-Hill, New York, p. 352.
42. Kaplan, E. L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457.
43. Matthews, D. E., and V. T. Farewell. 1988. The log-rank or Mantel-Haenszel test for the comparison of survival curves. In Using and Understanding Medical Statistics. D. E. Matthews and V. T. Farewell, eds. Karger, Basel, p. 79.
44. Siegel, S. Nonparametric Statistics. McGraw-Hill, New York, p. 1.
45. Hoglund, P., J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis, 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189:331.
46. Gagnerault, M. C., J. J. Luan, C. Lotion, and F. Lepault. 2002. Pancreatic lymph nodes are required for priming of β cell reactive T cells in NOD mice. J. Exp. Med. 196:369.
47. Hirt, B. 2000. Molecular biology of autonomous parvoviruses. Contrib. Microbiol. 4:163.
48. Jacoby, R. O., and L. J. Ball-Goodrich. 1995. Parvovirus infections of mice and rats. Semin. Virol. 6:329.
49. Karupiah, G., B. Coupar, I. Ramshaw, D. Boyie, R. Bianden, and M. Andrew. 1990. Vaccinia virus-mediated damage of murine ovaries and protection by virus-expressed interleukin-2. Immunol. Cell Biol. 68:325.
50. Mordes, J., J. Flanagan, J. Leif, D. Greiner, E. Kislauskis, A. Rossini, E. Blankenhom, J.-L. Hillebrands, and D. Guberski. 2003. Autoimmune diabetes in the LEW.IWRI rat after infection with Kilham rat virus (KRV) or rat cytomegalovirus (RCMV). Diabetes 52(Suppl. 1):A528.
51. Heine, H., and E. Lien. 2003. Toll-like receptors and their function in innate and adaptive immunity. Int. Arch. Allergy Immunol. 130:180.
52. Janeway, C. A., Jr., and R. Medzhitov. 1999. Innate immunity: Lipoproteins take their Toll on the host. Curr. Biol. 9:R879.
53. Medzhitov, R., and C. Janeway, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8:452.
54. Frantz, S., L. Kobzik, Y. D. Kim, R. Fukazawa, R. Medzhitov, R. T. Lee, and R. A. Kelly. 1999. Toll 4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104:271.
55. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
56. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732.
57. Like, A. A., D. L. Guberski, and L. Butler. 1991. Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/W or rats. Diabetes 40:259.
58. a haplotype rats. Diabetologia 43:890.
59. Segal, B. M., J. T. Chang, and E. M. Shevach. 2000. CPG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. J. Immunol 164:5683.
60. Ichikawa, H. T., L. P. Williams, and B. M. Segal. 2002. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J. Immunol. 169:2781.
61. Wen, L., J. Peng, Z. Li, and F. S. Wong. 2004. The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J. Immunol. 172:3173.
62. Deng, C., C. Radu, A. Diab, M. F. Tsen, R. Hussain, J. S. Cowdery, M. K. Racke, and J. A. Thomas. 2003. IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity. J. Immunol. 170:2833.
63. Conant, S. B., and R. H. Swanborg. 2004. Autoreactive T cells persist in rats protected against experimental autoimmune encephalomyelitis and can be activated through stimulation of innate immunity. J. Immunol. 172:5322.
64. Waldner, H., M. Collins, and V. K. Kuchroo. 2004. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J. Clin. Invest. 113:990.
65. Hermitte, L., B. Vialettes, P. Naquet, C. Allan, M.-J. Payan, and P. Vague. 1990. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus. Eur. J. Immunol. 20:1297.
66. Wilberz, S., H. J. Partke, F. Dagnaes-Hansen, and L. Herberg. 1991. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 34:2.
67. Leiter, E. H. 1998. NOD mice and related strains: origins, husbandry, and biology. In NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer and Other Diseases E. H. Leiter and M. A. Atkinson, eds. R.G. Landes, Austin, p. 1.
68. Atkinson, M., and E. H. Leiter. 1999. The NOD mouse model of insulin dependent diabetes: as good as it gets? Nat. Med. 5:601.
69. Serreze, D. V., H. R. Gaskins, and E. H. Leiter. 1993. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J. Immunol. 150:2534.
70. Serreze, D. V., J. W. Gaedeke, and E. H. Leiter. 1993. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc. Natl. Acad. Sci. USA 90:9625.
71. Naumov, Y. N., K. S. Bahjat, R. Gausling, R. Abraham, M. A. Exley, Y. Koezuka, S. B. Balk, J. L. Strominger, M. Clare-Salzler, and S. B. Wilson. 2001. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98:13838.
72. Wucherpfennig, K. W. 2001. Mechanisms for the induction of autoimmunity by infectious agents. J. Clin. Invest. 108:1097.
73. Harte, M. T., I. R. Haga, G. Maloney, P. Gray, P. C. Reading, N. W. Bartlett, G. L. Smith, A. Bowie, and L. A. O'Neill. 2003. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197:343.
74. Hawa, M. I., H. Beyan, L. R. Buckley, and R. D. G. Leslie. 2002. Impact of genetic and non-genetic factors in type 1 diabetes. Am. J. Med. Genet. 115:8.
75. Åkerblom, H. K., O. Vaarala, H. Hyöty, J. Ilonen, and M. Knip. 2002. Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet. 115:18.
76. Martin, A.-M., E. P. Blankenhorn, M. N. Maxson, M. Zhao, J. Leif, J. P. Mordes, and D. L. Greiner. 1999. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP BB/Wor rat to the WF rat. Diabetes 48:50.
77. Martin, A.-M., M. N. Maxson, J. Leif, J. P. Mordes, D. L. Greiner, and E. P. Blankenhorn. 1999. Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus: iddm4: additional evidence for a "universal autoimmunity locus" on rat chromosome 4. Diabetes 48:2138.
78. Mordes, J. P., J. Leif, S. Novak, C. DeScipio, D. L. Greiner, and E. P. Blankenhorn. 2002. The iddm4 locus segregates with diabetes susceptibility in congenic WF. iddm4 rats. Diabetes 51:3254.
79. Mordes, J., J. Leif, D. Greiner, and E. Blankenhorn. 2003. Iddm4 and at least one additional gene are required for diabetes expression in BBDR rats exposed to Kilham rat virus (KRV) and the Toll-like receptor (TLR) ligand polyinosinic: polycytidylic acid (poly I:C). Diabetes 52(Suppl. 1):A25.
80. Davis, C. T., E. P. Blankenhorn, and D. M. Murasko. 1984. Genetic variation in the ability of several strains of rats to produce interferon in response to polyriboinosinic-polyribocytoditic acid. Infect. Immun. 43:580.
81. Gillessen, S., D. Carvajal, P. Ling, F. J. Podlaski, D. L. Stremlo, P. C. Familletti, U. Gubler, D. H. Presky, A. S. Stern, and M. K. Gately. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:200.
82. Adorini, L. 2001. Interleukin 12 and autoimmune diabetes. Nat. Genet. 27:131.
83. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately, and L. Adorini. 1995. Interleukin 12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817.
84. Trembleau, S., G. Penna, S. Gregori, N. Giarratana, and L. Adorini. 2003. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-γ-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-γ. J. Immunol. 170:5491.
85. Zipris, D., D. L. Greiner, S. Malkani, B. J. Whalen, J. P. Mordes, and A. A. Rossini. 1996. Cytokine gene expression in islets and thyroids of BB rats: interferon γ and IL-12 p40 mRNA increase with age in both diabetic and insulin treated nondiabetic BB rats. J. Immunol. 156:1315.
86. Debray-Sachs, M., C. Carnaud, C. Boitard, H. Cohen, I. Gresser, P. Bedossa, and J. F. Bach. 1991. Prevention of diabetes in NOD mice treated with antibody to murine IFN γ. J. Autoimmun. 4:237.
87. Nicoletti, F., I. Congel, M. Di Mauro, R. Di Marco, M. C. Mazzarino, K. Bendtzen, A. Messina, and R. Gomis. 2002. Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107.
88. Bradley, L. M., V. C. Asensio, L. K. Schioetz, J. Harbertson, T. Krahl, O. Patstone, N. Woolf, I. L. Campbell, and N. Sarvetnick. 1999. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J. Immunol. 162:2511.
89. Vanguri, P., and J. M. Farber. 1990. Identification of CRG-2: an interferon-inducible mRNA predicted to encode a murine monokine. J. Biol. Chem. 265:15049.
90. Blackwell, S. E., and A. M. Krieg. 2003. CpG-A-induced monocyte IFN-γ-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-α. J. Immunol. 170:4061.
91. Matikainen, S., J. Pirhonen, M. Miettinen, A. Lehtonen, C. Govenius-Vintola, T. Sareneva, and I. Julkunen. 2000. Influenza A and Sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology 276:138.
92. Liu, M. T., B. P. Chen, P. Oertel, M. J. Buchmeier, D. Armstrong, T. A. Hamilton, and T. E. Lane. 2000. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J. Immunol. 165:2327.
93. Salazar-Mather, T. P., T. A. Hamilton, and C. A. Biron. 2000. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J. Clin. Invest. 105:985.
94. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168:3195.